SPARX PROTEIN
Dead / Abandoned — Abandoned — after inter partes decision (as of 10 Dec 2024)
What this means for you
This application is over — abandoned 10 Dec 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88861317
- Mark type
- Word mark
- Filed
- 06 Apr 2020
- Published for opposition
- 16 Apr 2024
- Abandoned
- 10 Dec 2024
- Attorney of record
- AARON D. HENDELMAN
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for targeting tissues based on select tissue markers and ligands for use in cancer treatment and immunotherapy; pharmaceutical preparations for the purpose of binding ligands using engineered polypeptides and receptors for use in cancer treatment and immunotherapy; none of the foregoing for gene therapy or for the diagnosis or treatment of genetic, retinal, or hematologic diseases and disorders
Owner
- Arcellx, Inc., Redwood City, CA, US
- Arcellx, Inc., Redwood City, CA, US
Prosecution history
- 10 Dec 2024 — ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
- 10 Dec 2024 — ABANDONMENT - AFTER INTER PARTES DECISION
- 10 Dec 2024 — OPPOSITION TERMINATED NO. 999999
- 10 Dec 2024 — OPPOSITION DISMISSED NO. 999999
- 13 Oct 2024 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 11 Oct 2024 — OPPOSITION INSTITUTED NO. 999999
- 14 May 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 16 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Apr 2024 — PUBLISHED FOR OPPOSITION
- 27 Mar 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Mar 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Feb 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 13 Feb 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Feb 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED